Sio Gene Therapies Inc reports results for the quarter ended in June - Earnings Summary

Sio Gene Therapies

12/08/2021 15:36

* Sio Gene Therapies Inc  SIOX.OQ  reported a quarterly adjusted
loss of 16 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 18 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Sio Gene Therapies Inc's reported EPS for the quarter was a
loss of 16 cents​.
* The mean earnings estimate of analysts had risen by about 20%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sio Gene Therapies Inc shares had fallen by 28.6% this
quarter and lost 29.9% so far this year.
* The company reported a quarterly loss of $11.87 million.
* Wall Street's median 12-month price target for Sio Gene
Therapies Inc is $8.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 02:36 p.m.  ​All
figures in US dollars unless otherwise stated